Search research articles
Contact Us
Filters
Showing results (331-340 of 336) with videos related to
Page
of 34
Sort By:
You have reached the last page of results.
This site can display upto 336 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 4, 2023
Interactive Effects of Molecular, Therapeutic, and Patient Factors on Outcome of Diffuse Low-Grade Glioma
Shawn L Hervey-Jumper, Yalan Zhang, Joanna J Phillips, et al.
The New England Journal of Medicine
|
June 11, 2015
Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors
Jeanette E Eckel-Passow, Daniel H Lachance, Annette M Molinaro, et al.
JAMA Oncology
|
February 7, 2020
Association of Maximal Extent of Resection of Contrast-Enhanced and Non-Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed Glioblastoma
Annette M Molinaro, Shawn Hervey-Jumper, Ramin A Morshed, et al.
The Lancet. Oncology
|
November 27, 2025
A prognostic classification system for extent of resection in IDH-mutant grade 2 glioma: an international, multicentre, retrospective cohort study with external validation by the RANO resect group
Philipp Karschnia, Jacob S Young, Maarten M J Wijnenga, et al.
Cell
|
May 2, 2024
RNA aggregates harness the danger response for potent cancer immunotherapy
Hector R Mendez-Gomez, Anna DeVries, Paul Castillo, et al.
Nature
|
November 22, 2019
Longitudinal molecular trajectories of diffuse glioma in adults
Floris P Barthel, Kevin C Johnson, Frederick S Varn, et al.
Page
of 34
Search research articles
Search
Showing results (331-340 of 336) with videos related to
Sort By:
Page
of 34
You have reached the last page of results.
This site can display upto 336 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 4, 2023
Interactive Effects of Molecular, Therapeutic, and Patient Factors on Outcome of Diffuse Low-Grade Glioma
Shawn L Hervey-Jumper, Yalan Zhang, Joanna J Phillips, et al.
The New England Journal of Medicine
|
June 11, 2015
Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors
Jeanette E Eckel-Passow, Daniel H Lachance, Annette M Molinaro, et al.
JAMA Oncology
|
February 7, 2020
Association of Maximal Extent of Resection of Contrast-Enhanced and Non-Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed Glioblastoma
Annette M Molinaro, Shawn Hervey-Jumper, Ramin A Morshed, et al.
The Lancet. Oncology
|
November 27, 2025
A prognostic classification system for extent of resection in IDH-mutant grade 2 glioma: an international, multicentre, retrospective cohort study with external validation by the RANO resect group
Philipp Karschnia, Jacob S Young, Maarten M J Wijnenga, et al.
Cell
|
May 2, 2024
RNA aggregates harness the danger response for potent cancer immunotherapy
Hector R Mendez-Gomez, Anna DeVries, Paul Castillo, et al.
Nature
|
November 22, 2019
Longitudinal molecular trajectories of diffuse glioma in adults
Floris P Barthel, Kevin C Johnson, Frederick S Varn, et al.
Page
of 34